Literature DB >> 3098385

Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.

F Ismail, S Epstein, R Pacifici, D Droke, S B Thomas, L V Avioli.   

Abstract

Bone gla protein, the vitamin K-dependent protein synthesized by osteoblasts and measured in blood by radioimmunoassay, has been used as an index of the rate of bone turnover. The relationship of bone gla protein with other markers of bone mineral metabolism was determined in 31 untreated postmenopausal women with the osteoporotic syndrome. In addition to serum osteocalcin (BGP) we measured parathyroid hormone (PTH) (carboxyl and mid-molecule fragments), 25(OH)D, alkaline phosphatase, estradiol (E2), estrone (E1), dietary calcium intake, 24 hour urinary calcium excretion, and bone mineral density by CT scan of the lumbar vertebrae. Significant osteopenia was present on CT in untreated postmenopausal osteoporotic women (bone density in 18 out of 31 was below the critical value of 60 mg/cm3). Serum BGP correlated positively with CT scan (r + 0.647, P less than 0.001). CT and age were negatively correlated (r - 0.661, P less than 0.001) while CT and E2 showed a positive correlation (r + 0.554, P less than 0.01). Unexpectedly, BGP and age revealed a significant negative correlation (r - 0.421, P less than 0.05). These findings suggest a state of low bone turnover in this group with untreated postmenopausal osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098385     DOI: 10.1007/bf02555209

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  11 in total

1.  Competitive protein-binding radioassay for 25-hydroxycholecalciferol.

Authors:  J G Haddad; K J Chyu
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

2.  Evidence for two distinct syndromes of involutional osteoporosis.

Authors:  B L Riggs; L J Melton
Journal:  Am J Med       Date:  1983-12       Impact factor: 4.965

3.  The aetiology of senile osteoporosis: secondary hyperparathyroidism due to renal failure.

Authors:  G M Berlyne; J Ben-Ari; A Kushelevsky; A Idelman; D Galinsky; M Hirsch; R Shainkin; R Yagil; M Zlotnik
Journal:  Q J Med       Date:  1975-07

4.  Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis.

Authors:  J P Brown; P D Delmas; L Malaval; C Edouard; M C Chapuy; P J Meunier
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

5.  Differences in serum bone GLA protein with age and sex.

Authors:  S Epstein; J Poser; R McClintock; C C Johnston; G Bryce; S Hui
Journal:  Lancet       Date:  1984-02-11       Impact factor: 79.321

6.  Parathyroid function in primary osteoporosis.

Authors:  B L Riggs; C D Arnaud; J Jowsey; R S Goldsmith; P J Kelly
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

7.  Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease.

Authors:  C M Gundberg; J B Lian; P M Gallop; J J Steinberg
Journal:  J Clin Endocrinol Metab       Date:  1983-12       Impact factor: 5.958

8.  Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.

Authors:  P D Delmas; H W Wahner; K G Mann; B L Riggs
Journal:  J Lab Clin Med       Date:  1983-10

9.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.

Authors:  P A Price; J G Parthemore; L J Deftos
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

10.  Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of Iliac crest bone from untreated patients.

Authors:  M P Whyte; M A Bergfeld; W A Murphy; L V Avioli; S L Teitelbaum
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

View more
  8 in total

1.  Oral contraception affects osteocalcin serum profiles in young women.

Authors:  R Karlsson; S Eden; B von Schoultz
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

2.  BGP (osteocalcin, bone-Gla-protein) in involutional osteoporosis.

Authors:  A Rapado; C de la Piedra; R Torres
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

3.  Serum osteocalcin and fracture susceptibility in elderly women.

Authors:  K Akesson; S Ljunghall; P Gärdsell; I Sernbo; K J Obrant
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

4.  Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss.

Authors:  M H Knapen; K S Jie; K Hamulyák; C Vermeer
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

5.  Tc-99m-HMDP bone uptake quantification and plasma osteocalcin levels in hemodialysis patients--a preliminary study.

Authors:  U Karayalcin; B Karayalcin; G Yakupoglu; A Yildiz; M Erkilic
Journal:  Ann Nucl Med       Date:  1992-02       Impact factor: 2.668

6.  Chlorpromazine alters bone metabolism of rats in vivo.

Authors:  T Komoda; A Nagata; M Kiyoki; M Miura; I Koyama; Y Sakagishi; M Kumegawa
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

7.  Osteocalcin and bone morphometric parameters in adults without bone disease.

Authors:  M Garcia-Carrasco; M Gruson; M C de Vernejoul; M A Denne; L Miravet
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

8.  Effects of Acupoint Application Therapy with TianGui Powder on Osteoporosis in Ovariectomized Rats through TGF-β1 and Smad2/3 Signaling Pathway.

Authors:  Xiao-Sheng Lin; Hai-Yan Wang; Zhen Zhang; Han-Jiao Liu; Zhen Qu; Ke-Liang Wu; Qing-Hua Xiao; Jian-Zong Zhu; Ping Zhang
Journal:  Orthop Surg       Date:  2019-02       Impact factor: 2.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.